Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes

NCT01918865 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Obese

Interventions

DRUG: ISIS-PTP1BRx
DRUG: Placebo
DRUG: daily OAD (metformin and/or sulfonylurea)

Sponsor

Ionis Pharmaceuticals, Inc.